CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,234 enrolled
Drug / intervention
3DCRT, IMRT, VMAT, SBRTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04595032
NCT04595032N/ACompleted
CompareCT.gov

MAnagement of METastatic Disease in Campania (MAMETIC): Role of Radiotherapy in an Italian Region: Protocol for an Observational Multicenter Trial

National Cancer Institute, Naples·observational·Posted Oct 20, 2020·Updated Nov 7, 2024

In Brief

An observational study evaluating 3DCRT, IMRT, VMAT, SBRT for Metastatic Disease. Completed, enrolled 3,234 participants across 1 site.

Detailed Summary

The MAMETIC Trial represents the first regional epidemiological study that aims to evaluate patients living in Campania with metastatic cancer, with the intent to detect different prevalence of tumors in the metastatic phase and evaluate the local response to the patient's request for assistance. Condition or disease: Metastatic disease Intervention/treatment: Radiation Treatment

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMetastatic Disease
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 20, 2020
Enrollment StartSep 11, 2020
Primary CompletionFeb 8, 2024
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 5.7 years ago

Interventions

3DCRT, IMRT, VMAT, SBRTdevice

Radiation treatment